CraniUS
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1700 Union Ave Ste A1, Baltimore, Maryla...Website
www.craniusmed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About CraniUS
CraniUS Therapeutics is a neurotechnology and medical device company developing innovative systems for direct drug delivery to the brain. Its flagship implantable platform, NeuroPASS, is designed to bypass the blood brain barrier and deliver targeted treatments for neurological conditions such as brain tumors, Alzheimer disease, and Parkinson disease.Explore more
CraniUS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CraniUS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CraniUS
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CraniUS launches new products
Funding: Get notified immidiatlly once CraniUS has new funding data
Website visits: Recent activity has been detected on your website
Click to see if CraniUS had a recent Job posting/layoffs
Check if CraniUS has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CraniUS recently announced quarterly report
Check out if CraniUS is spiking on competitors!
CraniUS, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at CraniUS
Find 2 more new buyers
Compare Similar Companies to CraniUS
Compare insights from companies similar to CraniUS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CraniUS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CraniUS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CraniUS.
CraniUS financials insights
Gather financial insights about CraniUS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$19.4M
2026
Series B
$20M
CraniUS Tech Stack
A closer look at the technologies used by CraniUS
See more technologies
Most Recent Scoops
Funding
Funding
Award
Award
Executive Move
Board of Directors
Award
Award
Executive Move
Board of Directors
CraniUS News & Media
CraniUS Appoints World Leading Neurosurgeon to Join Board of Directors
Dr. Henry Brem joins CraniUS Board of Directors in further enhancing its mission to facilitate chronic and direct medicine delivery for treating brain disease. BALTIMORE, Nov. 15, 2022 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and...CraniUS raised a $19.4M Series A to develop its device fighting chronic brain diseases
The startup, which counts recent Johns Hopkins university alums among its senior-most employees, will put the funds toward developing prototypes of its flagship device for delivering medicine directly to patients' brains.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CraniUS
Sign Up For FreeTo access detailed company insights
CraniUS Therapeutics is a neurotechnology and medical device company developing innovative systems for direct drug delivery to the brain. Its flagship implantable platform, NeuroPASS, is designed to bypass the blood brain barrier and deliver targeted treatments for neurological conditions such as brain tumors, Alzheimer disease, and Parkinson disea... Read More
